evaluation of the effect for cardio vascular system by administrating EPA thrapy
Not Applicable
- Conditions
- hyperlipidemia
- Registration Number
- JPRN-UMIN000004024
- Lead Sponsor
- the university of Tokushima Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) with allergy for anti-lipid drug 2) severe chronic renal failure 3) severe liver failure 4) hypo-drug compliance 5) the patients with pregnancy 6) the patients who was judged not to be able to admit drug by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) FMD, ABI, pWV, IMA 2) Cardioechography 3) TG, HDL, LDL, MDA-LDL, lipd acid
- Secondary Outcome Measures
Name Time Method 1) liver function 2) Renal function 3) blood test(BNP, FBS, HbA1c, IRI) 5) BMI, waist